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Abstract The bacterial species Staphylococcus aureus,
including its methicillin-resistant variant (MRSA), finds
its primary ecological niche in the human nose, but is also
able to colonize the intestines and the perineal region.
Intestinal carriage has not been widely investigated despite
its potential clinical impact. This review summarizes
literature on the topic and sketches the current state of
affairs from a microbiological and infectious diseases’
perspective. Major findings are that the average reported
detection rate of intestinal carriage in healthy individuals
and patients is 20% for S. aureus and 9% for MRSA, which
is approximately half of that for nasal carriage. Nasal
carriage seems to predispose to intestinal carriage, but sole
intestinal carriage occurs relatively frequently and is
observed in 1 out of 3 intestinal carriers, which provides a
rationale to include intestinal screening for surveillance or
in outbreak settings. Colonization of the intestinal tract with
S. aureus at a young age occurs at a high frequency and
may affect the host’s immune system. The frequency of
intestinal carriage is generally underestimated and may
significantly contribute to bacterial dissemination and
subsequent risk of infections. Whether intestinal rather than
nasal S. aureus carriage is a primary predictor for infections
is still ill-defined.
Introduction
Nasal colonization by Staphylococcus aureus is a well-
established risk factor for acute cutaneous infections, post-
operative infections, as well as most other types of S.
aureus infections [1–3]. Several recent studies have
suggested that lasting colonization of S. aureus in the
human intestinal tract also occurs and that this may have
important clinical implications. Still, compared to nasal
carriage, gastro-intestinal colonization by S. aureus has
been sparsely studied.
In the 1950s and 1960s, intestinal S. aureus carriage was
first defined and studied as a potential cause of antibiotic-
associated diarrhea (AAD) [4]. However, after the identifi-
cation of Clostridium difficile as the most common pathogen
of hospital-acquired AAD in the 1970s [5], the role of
gastro-intestinal colonization as a risk factor for (intestinal)
S. aureus infection has been neglected for decades and the
issue has only recently re-emerged. The pandemic rise in the
incidence of methicillin-resistant S. aureus (MRSA) strains,
as opposed to methicillin-sensitive S. aureus (MSSA), has
contributed greatly to the renewed interest in intestinal S.
aureus colonization. This covered investigations into risk
factors for both AAD as well as health care-associated (HA)
infections. Furthermore, community-acquired (CA) MRSA
infection among individuals without “HA risk factors” was
first recognized in the late 1990s. CA-MRSA is now
emerging as an apparent epidemic. In recent studies, in
addition to nasal carriage, rectal carriage of CA-MRSA has
also been documented. In this review we will give an
historical update and a systemic overview of the more recent
studies related to intestinal and/or perineal carriage of S.
aureus (MSSA, HA-MRSA, and CA-MRSA) and we will
discuss its clinical implications.
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Culture methods and definition of perineal
and intestinal carriage
Techniques to determine carriage or colonization can be based
on classical culture assays using selective broths or agars for
MSSA, as well as novel growth-based phenotypic and
molecular methods for both MSSA and MRSA detection
[6]. Methods used to define intestinal carriage include
culture of stool, rectal swabs or anal swabs. Also, swabs
from the perianal area (including the perineum and the groin
or inguinal region) are generally accepted to define intestinal
carriage. For these sites, however, it can be argued that these
may also represent skin carriage. In a limited number of
reports direct comparison of the frequency yields for these
different sites of colonization within the same study have
been presented. Rectal swabs were reported to have higher
yields of S. aureus detection than stool cultures [7], but a
more recent comparison [8] gave opposite results for MRSA.
Other studies reported similar frequencies of carriage for
both perianal and groin sites of carriage for nursing home
residents and hospitalized patients respectively [9, 10]. Also,
direct comparisons of the rectal and perineal sites gave
similar frequencies of detection [11] and in another recent
study screening of the perineal area, the rectum and the
inguinal area gave similar frequencies of detection of MRSA
[12], which legitimates the use of all of these sites to define
intestinal carriage.
Intestinal carriage frequencies of S. aureus in adults
Most early studies on the intestinal carriage of S. aureus
were performed on hospitalized patients and timely over-
views of frequencies of intestinal carriage in adults upon
admission to the hospital were reported [4, 13]. The
frequencies found in these relatively ancient studies ranged
from 8 to 31% (Table 1). Among adults, nasal S. aureus
carriers were reported to yield S. aureus from their feces
more often than non-nasal carriers did. Strain typing
suggested involvement of the same strains for both
colonization sites [14]. Vice versa, about 50–70% of
perineal carriers were also nasal carriers of the same strain
[15]. It was reported that of 50 healthy male students
screened, 11 (22%) had perineal carriage of S. aureus and
that 5 of these were non-nasal carriers (10%) [16]. This
implied that non-nasal carriers might be susceptible to
intestinal carriage, suggesting that mechanisms for nasal
and intestinal carriage differ.
More recent data on the intestinal carriage of S. aureus in
adults were generated as part of studies mostly aimed at
identifying MRSA. In most of these studies the patients
were screened for intestinal as well as nasal carriage,
allowing a comparison of these sites of colonization
(Table 2). For instance, in a study on 500 pregnant women
attending an antenatal clinic a frequency of intestinal
carriage of S. aureus of 12% (59 patients) and a nasal
carriage frequency of 24% (120 patients) were reported
[17]. Interestingly, 8% (41) of the patients had intestinal
carriage in the absence of nasal carriage, covering 25% of
all S. aureus-positive patients. Among patients in a skilled
nursing facility, nasal and rectal swabs or stools were
surveyed for MSSA and MRSA. Of these, 22% (76
patients) had intestinal carriage of S. aureus [18]. Ten
percent of the patients (n=34) were intestinal carriers in the
absence of nasal carriage.
The prevalence of S. aureus colonization of the perineum
was examined in a longitudinal study on 84 community-
dwelling adults with spinal cord dysfunction [19]. S. aureus
was detected in 20 (24%) individuals. Nasal carriage was
detected in 55% of all patients from a subset of 22 patients
of whom 23% had intestinal carriage only. By follow-up of
30 patients with at least five cultures for 1 year, the perineal
carriage pattern was assessed. They found that 10% had
persistent carriage, 63% had intermittent carriage, and 27%
were non-carriers, in agreement with nasal carriage patterns
[1]. Paired perineal/nasal carriage was determined for 22
participants. Of the 16 perineal carriers in this group, 5 did
not have nasal carriage. Among the 11 with both perineal
and nasal carriage, all but 1 carried the same spa type at both
sites. Many similar studies were performed, the results of
which are summarized in Table 2.
Altogether the frequency of nasal carriage detection of S.
aureus ranged from 24% to 61% and intestinal carriage
frequencies in these studies ranged from 10% to 37%.
These ranges probably reflect the different criteria used for
the selection of patient groups and the differences in risk of
S. aureus colonization or infection amongst these hetero-
geneous groups of patients from different geographical
regions. Therefore, calculation of an overall frequency of
S. aureus carriage from these studies by using actual total
numbers of patients may be debated, but, nevertheless,
results in approximately 20% of cases of intestinal carriage
Table 1 Reported frequencies of intestinal carriage of S. aureus in
adults upon admission to hospital in early studies
Reference Percentage positives
[92] 18
[93] 17
[14] 23
[94] 31
[95] 8
[16] 22
[96] 21
[15] 12
[97] 13
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compared with nasal carriage of approximately 40%. When
reported frequencies of the separate studies are plotted, it
appears as if there is a linear correlation between the
incidence of nasal and intestinal carriage (see Fig. 1). The
slope of the linear regression is 0.55, which suggests that
intestinal carriage is probably preceded by nasal carriage.
However, sole intestinal carriage also seems to occur with
frequencies ranging from 3–10%. When intestinal carriage in
the absence of nasal carriage is calculated from these studies
using actual numbers of patients a figure of 8% is obtained.
Furthermore, on average, 1 out of 3 intestinal carriers (37%)
does not seem to be colonized in the nares (Table 2).
Obviously, compared with nasal carriage the intestinal
carriage of S. aureus is less frequent, but still may have
important clinical consequences.
Intestinal MRSA in adult patients at high risk
During the last 2 decades, a number of studies have
reported intestinal screening to determine carriage of
MRSA beyond the nasal cavity, in patients at high risk of
MRSA at admission or during a stay in a hospital (Table 3).
Long-term care patients were analyzed and detection of
MRSA was reported in stools from 29 out of 354 patients
(8%) [18]. Nasal carriage frequency was 15% (52 patients).
The detection of 2 MRSA patients on the basis of 10 stool
cultures (20%), obtained during an outbreak in an institu-
tion for adults with developmental disabilities, was
reported, whereas nasal screening detected MRSA in 16
out of 28 patients (57%) [20]. A frequency of intestinal
carriage of 10% (8 out of 84) in community-dwelling
patients with spinal cord dysfunction was recorded [19].
Nasal screening of a subgroup of 22 of these patients
revealed a nasal MRSA frequency of 55% (12 patients).
Furthermore, 205 patients were analyzed who were known
to be previously colonized and/or infected with MRSA.
Intestinal carriage detection frequency was 33% and nasal
carriage detection frequency was 52% [21]. Many other
reports describing similar data are surveyed in Table 3.
When totals are calculated from these reports, the average
nasal carriage frequency in these patients at high risk was
12% and intestinal carriage frequency was 9%.
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Fig. 1 Relation between frequencies of nasal and intestinal carriage
for S. aureus (circles) and for MRSA (diamonds). Lines show the
linear regression of S. aureus (dotted line) and MRSA (straight line),
the slope of the linear regression lines are 0.55 and 0.53, and R2 are
0.6012 and 0.7381 for S. aureus and MRSA respectively. The plotted
data for S. aureus are extracted from: [3, 10, 17–19, 24, 44, 48, 77,
90] and for MRSA from: [10, 18–21, 23, 24, 27, 31, 33, 36, 38, 39,
51, 91]
Table 2 Frequencies of detection of S. aureus (including MRSA) with regard to intestinal and nasal carriage and intestinal carriage in the absence
of nasal carriage in adults
Reference Total
number of
patients
screened
Intestinal carriage,
percentage of
total (n) or
(n/total)
Nasal carriage,
percentage of
total (n) or
(n/totala)
Intestinal carriage
in the absence
of nasal carriage,
percentage of total
(n/totala)
Intestinal carriage
in the absence of
nasal carriage,
percentage of
intestinal carriers
(n/totala)
Method used Patient group
[17] 500 12 (59) 24 (120) 8 (41) 70 Perineal swabs Pregnant women
[77] 37 24 (9) 30 (15/50) NS NS Rectal swab Mothers 1 week after
delivery
[55] 62 11 (7) 44 (27) 3 (2) 29 Perineal swabs Healthy adults
[18] 354 22 (76) 61 (214) 10 (34) 45 Stools Private SNF patients
[48] 204 29 (59) 47 (96) 3 (7) 12 Rectal swabs ICU liver transplant patients
[24] 231 10 (24) 30 (70) 5 (11) 46 Perineal swabs Intensive care patients
[90] 94 37 (35) 49 (47/96) 10 (9) 26 Rectal swabs Liver transplant recipients
[44] 71 37 (26) 51 (36) 4 (3) 12 Stools Selected inpatients
[10] 213 25 (54) 43 (91) NS NS Perianal swabs Nursing home residents
Totals 1,766 20 (349/1,766) 40 (716/1,781) 8 (112/1,538) 37 (112/302)
NS, not specified; SNF, skilled nursing facilities; ICU, intensive care unit
a Totals are indicated when frequencies are based on a different total number of patients screened
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Interestingly, when frequencies of nasal and intestinal
MRSA carriage are plotted and compared with those
reported for S. aureus (Fig. 1) it seems that the incidence
of carriage of MRSA is lower than that for S. aureus for both
the nares and the intestines, which makes sense, since
MRSA has been emerging and disseminating as a colonizing
bacterium much more recently than S. aureus has. However,
the slope of the regression of 0.53 for MRSA is the same as
that determined for S. aureus (0.55), which indicates a
similar relation between both sites of carriage for MRSA and
suggests that antibiotic resistance does not influence the
relative colonization ability for these two sites.
Distribution of MRSA detection sites
Direct comparison of the distribution of intestinal carriers
versus nasal carriers amongst MRSA-colonized patient
groups could be deduced from 22 reports (Table 4) [9, 10,
13, 18, 19, 22–29, 31–39]. Table 4 surveys the frequency of
patients with intestinal carriage and nasal carriage
expressed as a percentage of all MRSA-colonized patients
found in the various studies. In general, patients were
considered colonized when at least two consecutive cultures
from any place in the body grew MRSA, but also single
colonization criteria were applied. The frequencies reported
ranged from 5 to 76% and from 34 to 84% for intestinal and
nasal carriage respectively. When the distribution of
intestinal and nasal carriage in MRSA-colonized patients
is calculated from all of these studies comprising more than
2,000 MRSA-colonized/infected patients, an overall contri-
bution of 45% is found for intestinal carriage and 58% for
nasal carriage for all MRSA-colonized patients.
In Table 4 the reported frequencies of intestinal MRSA
carriage in the absence of nasal carriage are also summa-
rized. For instance, in a study of an MRSA outbreak
involving a total of 975 MRSA patients, perineal screening
identified an additional 15% of culture-positive individuals
compared with nasal screening only [25]. In this study, the
intestines were reported to be the only positive site out of
five culture sites in 10% of the cases. Klotz and coworkers
reported that in addition to a high frequency of 24%
MRSA-positive stool cultures, 13% of the MRSA strains
were first observed in the stool before detecting MRSA in
other material from these patients [30]. Similarly, in a large
Canadian surveillance study [40], comprising more than
10,000 adult patients, the perineal area was found to be the
initial site of MRSA colonization or infection in 41% of the
cases. In patients older than 65 years of age, the perineum
or rectum was the only positive site in 13%, indicating that
nasal screening alone would be sub-optimal in elderly
patients. More recently, Zhang et al. [39] reported that nasal
screening alone would have detected 76% of MRSA
carriers and that the inclusion of rectal screening increased
the detection sensitivity to 96%, indicating 20% rectal
carriers without nasal carriage. Reyes et al. [36] reported an
intestinal carriage frequency without nasal carriage in 27%
of their MRSA-positive patients, whereas Mody et al. [10]
showed that 23% of their MRSA carriers were only
colonized in the perianal area. Altogether, comparisons of
rates of nasal and intestinal carriage of MRSA were
recorded in 16 of the studies mentioned (Table 4). It can
be calculated from these studies that of all MRSA colonized
patients, 58% were colonized in the nares, whereas 45%
were colonized in the intestines. Of the individuals with
gastro-intestinal MRSA, 1 out of 3 (35%) did not carry
Table 3 The MRSA intestinal carriage and nasal carriage detection frequencies in hospitalized adult patients at high risk
Reference Total patients screened Intestinal MRSA, percentage of total (n) Nasal MRSA percentage of total (n/totala) Method used
[18] 354 8 (29) 15 (52) Stools
[38] 114 5 (6) 14 (16) Rectal swabs
[51] 327 11 (36) 24 (117/484) Stools
[20] 10 20 (2) 57 (16/28) Perineal swabs
[33] 411 5 (22) 7 (31) Perineal swabs
[91] 105 10 (10) 13 (34/256) Perineal swabs
[24] 231 5 (11) 10 (23) Perineal swabs
[27] 1,250 5 (57) 7 (90) Rectal swabs
[23] 192 10 (20) 13 (25) Groin swabs
[31] 1,181 13 (151) 13 (155) Groin swabs
[39] 845 6 (54) 6 (54) Rectal swabs
[19] 84 24 (20) 37 (17/46) Perineal swabs
[21] 52 33 (17) 52 (53/101) Groin swabs
[36] 758 8 (60) 8 (57) Perineal swabs
[10] 213 16 (35) 26 (56) Perineal swabs
Totals 6,127 9 (530/6,127) 12 (796/6,464)
a Totals are indicated when frequencies are based on different numbers of total patients screened.
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MRSA in the nose. Of all MRSA-colonized individuals
detected in these studies more than 1 out of 6 (18%) presented
with intestinal carriage in the absence of nasal carriage. Such
frequencies suggest that the intestines might be clinically
relevant reservoirs ofMRSA that should be taken into account
during screening for such carriage during outbreak situations
or when screening patients at risk.
Intestinal or perineal carriage as a risk factor
for dissemination and infections
The perineum, as an area where S. aureus can colonize and
multiply, was first recognized by Hare and Ridley [41], and
heavy contamination from the perineum to the groin and
upper parts of the thighs is often observed [42]. Both
intestinal and perineal carriage have been implicated as
important contributors to environmental dissemination of S.
aureus. Patients with intestinal colonization of S. aureus
may serve as an important source of transmission, since
they often contaminate the adjacent environment. Masaki et
al. [43] performed a prospective culture survey to investi-
gate a possible relationship between S. aureus types
colonizing the rectum and respiratory tract and S. aureus
types isolated from the environment. They simultaneously
detected in both patients and the environment several S.
aureus types. This indicates a potential route of contami-
nation of the hospital environment. It was also reported that
Table 4 Distribution of intestinal and nasal carriage in all MRSA-colonized patients detected in the studies
References Total
MRSA
cases
Intestinal MRSA,
percentage of
total (n)
Nasal MRSA,
percentage of
total (n/totala)
Intestinal without
nasal, percentage
of total (n)
Intestinal without
nasal, percentage
of intestinal carriers
Method used Patient group
[22] 63 5 (3) 34 (24/79) Not specified Not specified Perineal swabs General hospital patients,
MRSA outbreak
[13] 117 61 (70) 53 (62) Not specified Not specified Rectal swabs General hospital patients,
MRSA outbreak
[26] 11 18 (2) 55 (6) 0 (0) 0 Anal swabs SCI patients
[32] 67 25 (17) 58 (37) Not specified Not specified Perineal swabs SCI patients
[25] 723 40 (289) 47 (369/789) 15 (145) 50 Perineal swabs Hospital MRSA outbreak
[18] 62 47 (29) 84 (52) 16 (10) 35 Stools Private skilled nursing
facility patients
[35] 23 17 (4) 65 (15) 9 (2) 50 Perineal swabs Acute care patients
[34] 19 42 (8) 68 (13) 5 (1) 13 Perineal swabs Acute rehabilitation unit
SCI patients
[38] 24 25 (6) 67 (16) 8 (2) 33 Rectal swabs Skilled care unit patients
[33] 51 54 (22) 61 (31) 18 (9) 41 Perianal swabs Acute rehabilitation unit
[37] 36 50 (18) 75 (27) 25 (9) 50 Groin swabs General hospital, at risk
patients
[28] 203 26 (52) 44 (89) Not specified Not specified Perineal swabs Neurosurgery unit patients
[29] 35 20 (7) 75 (21) Not specified Not specified Perineal swabs General hospital, at risk
patients
[24] 30 37 (11) 77 (23) 17 (5) 46 Perineal swabs ICU patients
[9] 96 49 (47) 72 (72) Not specified Not specified Perineal swabs University hospital, at risk
patients
[27] 123 46 (57) 73 (90) 19 (23) 40 Rectal swabs ICU patients
[23] 31 65 (20) 80 (25) 19 (6) 30 Groin swabs General hospital, at risk
patients
[31] 224 67 (151) 69 (155) 12 (26) 17 Groin swabs ICU patients
[39] 71 76 (54) 76 (54) 20 (14) 26 Rectal swabs General hospital, at risk
patients
[19] 22 73 (16) 71 (12/17) 30 (5) 31 Perineal swabs Community-dwelling SCD
patients
[36] 78 77 (60) 73 (57) 27 (21) 35 Perineal swabs ICU patients and other risk
factors
[10] 86 41 (35) 65 (56) 11 (9) 11 Perianal swabs Nursing home residents
Totals 2,195 45 (978/2,195) 58 (1,306/2,268) 18 (287/1,614) 35 (287/833)
SCI, spinal cord injury; SCD, spinal cord dysfunction
a Totals are indicated when frequencies reported are based on different total numbers of cases
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patients with intestinal and nasal colonization of S. aureus
had higher frequencies of incontinence or diarrhea than
patients without S. aureus colonization. This may signifi-
cantly contribute to the observed trend toward increased
contamination of environmental surfaces [44, 45]. The
latter studies also substantiated that patients who have
diarrheal stools and heavy gastro-intestinal colonization
with MRSA are associated with significantly greater
environmental MRSA contamination than patients without
MRSA in their stools.
Data from early studies suggested an association
between intestinal colonization and the occurrence of
infections. For example, a study on recurrent furunculosis
showed that 56% of the patients sampled had positive
perineal cultures [46]. This suggested intestinal S. aureus
carriage to be an infection risk factor, although nasal
carriage was not precisely assessed for those patients.
Hospitalized patients who reported developing S. aureus
lesions on the buttocks and lower half of the abdomen and
back often had the causative strain isolated from the
perineum as well [47]. It was found that intensive care
and liver transplant unit patients with both nasal and
intestinal colonization had significantly increased rates of
S. aureus infection of 40% compared with an infection rate
of 18% in patients with nasal carriage without intestinal
carriage [48]. On the basis of these data it was concluded
that rectal carriage represents a potential reservoir and
simultaneous nasal and rectal carriage portended a greater
risk of S. aureus infections than nasal carriage alone in ICU
and liver transplant unit patients. The same authors also
proposed that intestinal colonization could be associated
with an increased frequency of colonization of skin sites,
which was confirmed in later studies [44]. It was found that
patients with nasal and intestinal colonization were signifi-
cantly more likely than those with nasal colonization only to
have positive skin cultures. This group performed a prospec-
tive study involving 71 patients. The patients enrolled were
divided into three groups: those without nasal or intestinal
colonization, those with nasal colonization only, and those
with both nasal and intestinal colonization. The development
of S. aureus infections was significantly different among the
three groups. Only 1 out of 32 patients without nasal or
intestinal colonization developed an S. aureus infection. S.
aureus infections developed more often in patients with stool
colonization (8 out of 26) than in patients with only nasal
colonization (2 out of 13). However, due to the small
number of infected patients the power of this study was too
limited to reach statistical significance. Significant differ-
ences in staphylococcal infection between patients with S.
aureus in the stools and patients with negative stool cultures
for S. aureus were documented [49]. In an 8-month
prospective study of inpatients known to have vancomycin-
resistant enterococci (VRE) colonization, none of the 14
patients with stool cultures negative for S. aureus developed
an S. aureus infection in the hospital. In contrast, more than
half of S. aureus-colonized patients had an S. aureus
infection documented.
Eradication of intestinal carriage
Given its relatively high incidence, prevention of or therapy
for intestinal carriage should be clinically beneficial.
However, most studies are focused on the elimination of
nasal rather than intestinal carriage. Nasal carriage eradica-
tion with mupirocin ointment has been studied frequently
(recently reviewed by Van Rijen et al. [50]) and is generally
considered to be highly effective, at least in the short term.
However, reacquisition of carriage may occur from extra-
nasal sites. Dupeyron et al. [51] monitored mupirocin
treatment of 86 patients and found treatment failure in 22.
For this group, the stool carriage rate was significantly
higher and stool carriage upon admission was independent-
ly associated with reacquisition of nasal carriage.
Conflicting results regarding the effects of nasal carriage
eradication on the prevalence of MSSA/MRSA infections
have been reported. Some authors showed significantly
decreased rates of nosocomial infections [52, 53], whereas
others did not [54, 55].
Mupirocin treatment may only be marginally effective in
the eradication of multi-site carriage and, therefore, thera-
pies based upon combinations of nasal, skin, and intestinal
carriage eradication methods have more recently been
exploited. The use of oral rifampin, for treatment of
intestinal carriage of S. aureus for various patient popula-
tions and healthy people was reviewed by Falagas et al. [56,
57]. Rifampin, however, showed limited success in MRSA
elimination. More novel treatment modalities for intestinal
MRSA elimination to control transmission or subsequent
infections, e.g., using oral vancomycin, have been de-
scribed merely in uncontrolled or observational studies.
Oral vancomycin treatment results were reported that
showed that the eradication of MRSA intestinal carriage
by enteral vancomycin in subsets of adult ICU patients [58–
60] as well as in pediatric patients [61, 62] was effective,
but had limited effect on the prevention of transmission.
The results from prospective controlled studies of intestinal
MRSA decolonization are urgently awaited.
Colonization of the intestinal tract by S. aureus may have
another important clinical implication. The co-existence of
S. aureus and VRE was reported in more than 50% of the
American patients studied [49]. In this study, stool speci-
mens were tested for VRE and S. aureus at enrollment
(baseline) and weekly thereafter. Patients with at least three
stool cultures were included in the study. Of the 37 patients
who completed the study, all were colonized with VRE; 62%
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were colonized with S. aureus on at least one occasion, and
60% were colonized persistently. Patients with stool cultures
positive for S. aureus were colonized with MRSA strains in
87% of all cases. Warren et al. [63] screened stools and rectal
samples from 878 ICU patients for VRE and MRSA. Of 485
VRE-positive patients, 83 (17%) also had intestinal carriage
of MRSA. Furuno et al. [64] reported that out of 57 patients
with both nasal MRSA carriage and intestinal VRE, 23
(40%) also had intestinal carriage of MRSA. These studies
suggest that the intestinal tract could provide an important
reservoir for the emergence of vancomycin-resistant S.
aureus (VRSA) isolates
The emergence of the rectal carriage of CA-MRSA has
been documented in a study in which S. aureus was
detected in 507 of 2,963 vaginal/rectal cultures from late
pregnancy cases (17%) [65]. Interestingly, 3% of the
pregnant women had vaginal–rectal colonization of an
epidemic CA-MRSA strain. A significant association
between S. aureus colonization and Group B streptococcus
(GBS) colonization was found. In a subsequent study this
association was analyzed in more detail [66] and the
significant association between MSSA and GBS was
confirmed. Pregnant women with MSSA carriage were
significantly more likely to have postpartum fever than
those who were S. aureus-negative. Surprisingly, a signif-
icant negative association between CA-MRSA carriage and
GBS carriage was observed. Apparently, when a certain
bacterial species inhabits a given niche other species may
not be able to colonize. In the case of the vaginal carriage
of MRSA or MSSA such bacterial interference may lead to
novel modes of intervention based on interference therapy
of GBS once the microbial molecules involved have been
identified.
Potential role of S. aureus in intestinal disease
How S. aureus causes intestinal infections is still ill-defined.
The basic mechanisms are quite enigmatic and the etiolog-
ical processes are just beginning to be identified. For
instance, Froberg et al. [67] presented histo-pathological
evidence for the existence of a specific S. aureus-induced
pseudomembranous intestinal disease, distinct from that seen
during C. difficile infection in an unusual case of simulta-
neous infection with C. difficile and MRSA. Whereas C.
difficile induces colonic pseudomembranes, the MRSA
infection induced loosely adherent pseudomembranes in the
small bowel.
Intestinal carriage of S. aureus may impose a risk factor
for intestinal infection. Antibiotic treatment can lead to the
overgrowth of bacteria in the intestine and induce enteritis
or AAD. The role of intestinal S. aureus as a causative
agent for enteritis or AAD and as a risk factor for other
infections gained renewed interest with the spreading of
MRSA. MRSA has been suggested as a cause of AAD in
hospitalized patients [68]. In this study S. aureus was the
only identified pathogenic micro-organism to cause AAD in
47 patients and the presence of staphylococcal enterotoxin
A was strongly associated with the development of
diarrhea. A German study reported intestinal carriage of S.
aureus, in the absence of C. difficile in 8% of patients with
AAD [69]. Compelling evidence for the etiological role of
MRSA in AAD was provided by excluding the involve-
ment of C. difficile, numerous other bacterial pathogens and
parasites, but also several enteric viruses in 11 patients with
enterotoxin-producing MRSA intestinal carriage [70].
An extensive analysis of the prevalence of C. difficile
and S. aureus in 2,727 stool samples of patients with
diarrhea was performed. C. difficile grew from 148 speci-
mens and 184 were positive for C. difficile toxin A/B
analysis and altogether, a total of 252 stool samples were
positively diagnosed with C. difficile. S. aureus was grown
out of 198 fecal samples, of which 29 were identified as
having MRSA [71]. In another study 10 MRSA-positive
samples were detected out of 4,659 fecal samples [72].
Table 5 conclusively defines the interrelatedness between
intestinal colonization by S. aureus and C. difficile.
Intestinal S. aureus colonization and disease
development in infants and young children
In infants very high frequencies for intestinal S. aureus
carriage were reported in early studies (reviewed by
Williams [4], Table 6) and some of these suggested that
acquisition of S. aureus occurred very early in life and
probably as a consequence of nasal acquisition. Intestinal
colonization in children was also studied more recently
[73]. One hundred patients, below 16 years of age and
attending the emergency department of a university
hospital, who were analyzed for nasal and perineal carriage,
included 20 S. aureus-colonized patients, of whom 2 (10%)
had intestinal carriage in the absence of nasal carriage. Of
this group, 17 patients (85%) had nasal carriage. Others
studied S. aureus carriage in a child care center [74]. Of
Table 5 Frequency of detection of C. difficile and S. aureus in
antibiotic-associated diarrhea (AAD) patients
Reference Total C. difficile,
percentage (n)
S. aureus,
percentage (n)
[68] 3,437 13 (460) 2 (60)
[70] 1,543 10 (159) 10 (151)
[69] 89 44 (39) 28 (25)
[72] 4,659 13 (591) 0.2 (10)
[71] 2,727 9 (252) 7 (198)
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128 children who had swabs taken from nose, perineum,
and throat, 8 (24%) had perineal carriage. Nasal and throat
carriage frequency were higher with 15 (46%) and 22
(67%) respectively. An African study investigated the
incidence of S. aureus in children aged 5 years and below
suffering from sporadic diarrhea in Nigeria [75]. Out of
1,761 diarrheic fecal specimens collected, only 72 (4%)
were positive for S. aureus.
Also, in more recent Swedish studies [76–79], high
frequencies of intestinal S. aureus carriage during the first
year of life were reported, and co-colonization of intestine
and anterior nares with the same S. aureus strains, which
were also found on the parents, suggested mother- to-child
transmission. These studies were performed to test the
hypothesis that development of allergic disease among
children may be associated with differences in intestinal
colonization patterns of S. aureus. Two-year-old allergic
children from both Sweden and Estonia were reported to
have significantly higher counts of S. aureus in the
intestines than non-allergic children [76]. In a prospective
follow-up study, significantly increased S. aureus intestinal
prevalence at 6 months of age was found in a group of
allergic children compared with the non-allergic group. An
interesting correlation between intestinal colonization with
S. aureus at 2 and 4 weeks of age and the development of
food allergy was observed by Lundell et al. [79]. They also
found a correlation between perinatal intestinal S. aureus
colonization and expression levels of the soluble immune
modulator CD14, but not the levels of CD83, and
concluded that colonization with S. aureus might modulate
the development of the neonatal immune system. This
indicates an interrelatedness between factors involved in the
host’s immune response, early colonization, and develop-
ment of allergic disease. Adlerberth et al. [80] studied the
hypothesis that infantile intestinal colonization patterns may
influence sensitization to food allergens and atopic eczema.
They analyzed a birth cohort of more than 300 infants from
three European countries with regard to relations between
intestinal colonization patterns during the first year and the
development of atopic eczema and sensitization at
18 months of age. They reported a nearly significant
association (p=0.06) between early intestinal colonization
with S. aureus and increased risk of atopic eczema.
Kalliomaki et al. [81] recently observed that higher
numbers of fecal S. aureus carriage at 6 and 12 months of
age were associated with obesity in children.
Bisgaard et al. [82], who studied a Danish birth cohort of
411 infants, did not observe any correlation between
neonatal airway colonization with S. aureus at 1 month of
age and the development of childhood asthma. In contrast,
for colonization with the classical otitis media bacteria S.
pneumonia, M. catarrhalis and H. influenzae a significant
association with increased persistent or acute wheezing and
hospitalization for wheezing was observed. This seems to
indicate a lack of influence of S. aureus colonization.
However, since these studies were performed in a high-risk
cohort, an alternative plausible interpretation of these data
is that S. aureus to a greater extent than the other bacteria
mentioned may modulate the neonatal immune system, and
that the lower rates of wheezing associated with S. aureus
colonization may actually reflect relative protection. This
may be in line with observed differences in immune
induction between gram-positive and gram-negative bacte-
ria and the risk of childhood asthma [83]. The potential
involvement of S. aureus enterotoxins (SE) in allergic
diseases in early childhood by following 510 children from
birth to 5 years of age was studied by Semic-Jusufagic et al.
[84]. SE-mix-specific IgE, (SE-A, SE-C, and TSST-1) were
measured to determine SE sensitization and correlated with
atopic disease. Atopic children were nearly 4 times more
SE-mix-sensitive than non-atopic children. Children with
eczema were significantly more frequently SE-mix sensi-
Table 6 S. aureus intestinal carriage in infants
References Cases Percentage Method Age
[92] 83 56 Stools 1–10 days
22 100 2–6 months
32 50 6–
12 months
[76] 62 61 Stools 2 years
[73] 100 19 Perineal swabs Hospitalized
children up
to 16 years
[78] 49 16 Rectal/stools 3 days
57 1 week
65 2 weeks
65 4 weeks
73 8 weeks
73 6 months
53 1 year
[98] 44 59 Stools 1 week
61 1 month
50 3 months
39 6 months
32 12 months
[77] 50 20 Rectal/stools 3 days
40 1 week
52 2 weeks
60 4 weeks
64 8 weeks
[79] 53 62 Rectal swabs 2 weeks
70 4 weeks
[80] 324 13 Rectal swabs 3 days
39 7 days
52 14 days
63 28 days
72 2 months
79 6 months
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tized than children without and the SE-mix sensitization
rate increased significantly with increasing eczema severity.
SE-mix sensitization was also significantly associated with
current wheezing. Furthermore, SE-mix-sensitized children
with wheezing had significantly higher airway reactivity
than wheezing children who were not sensitized to SE-mix,
which suggests that enterotoxins from S. aureus might be
potential modifiers of childhood wheezing and eczema.
Intestinal MRSA in infants and young children at risk
Paired analysis of nasal and intestinal colonization during
separate outbreaks of MRSA in children and newborns has
been reported in a limited number of studies. After identifi-
cation of a single case of MRSA infection, 128 children from
a child care center were assessed for MSSA/MRSA carriage
by perianal, nasal, and throat swabs [74]. This analysis
identified an additional MRSA carrier only from the perianal
swab, whereas the two other sites were negative. Singh et al.
[85] found that during an MRSA outbreak at the neonatal
intensive care unit of two hospitals, out of 373 infants
analyzed, 24 were positive for MRSA. Of these, 7 (29%) had
positive rectal cultures, of whom 1 (0.4%) was negative for
nasal carriage. In 17 infants (71%) only the nasal culture was
positive. Investigations during two MRSA outbreaks (one
with a HA-MRSA and one with a CA-MRSA strain) were
performed using paired nasal and intestinal screening [86].
Altogether, 1,792 newborns were screened and 50 were
MRSA-positive. In the first hospital, out of 25 infants
positively screened, 17 (71%) had nasal carriage and 5
(21%) had carriage in the rectum, all of whom also had nasal
carriage. In the second hospital, 18 out of 25 positively
screened (72%) had nasal carriage and 15 out of 25 infants
(60%) had rectal carriage, of whom 3 (12%) did not have
nasal carriage. The use of surveillance cultures of throat and
rectal swabs in a pediatric intensive care unit is important
[62]. Among 1,241 patients analyzed there were 29 MRSA
carriers, of whom 14 (48%) had rectal carriage. Gustafsson
et al. [87] described a study on MRSA carriage in 23
children adopted by Swedish families. Multiple swabs were
taken from the perineum, nose, and other sites. MRSA was
detected in 13 of the children. The perineum culture was
positive at least once in 9 children (69%) and the nose
was positive in 9 children (69%). Interestingly, 4 perineal
MRSA carriers (31%) did not have nasal carriage.
Altogether, from these studies it can be deduced that of
all the newborns or young children in whom MRSA was
detected, 74% had nasal or throat carriage and 44% had
intestinal carriage (Table 7). Moreover, 10% had intestinal
carriage without nasal or throat carriage, which indicates
that, in addition to nasal or throat carriage, the perineum or
intestine also constitutes a colonization site with potential
infection risk in newborns and young children.
Concluding remarks
Intestinal carriage of S. aureus occurs in a significant
fraction of both healthy and diseased human individuals.
For healthy adults and hospitalized adults at risk the
incidence figure is 20%. For MRSA the average fraction
of intestinal carriers amongst adult patients at risk is 9%. In
young children the colonization of the intestines with S.
aureus occurs at a very high frequency within the first
6 months of life, after which the frequency drops. For
newborns and young children intestinal colonization with
MRSA was detected in 1–2% of patients screened. This
shows that the clinical impact of this phenomenon may be
significant, which was corroborated in a number of studies
that associated carriage and intestinal infection. Both
MSSA and MRSA seem to successfully colonize the
human intestines. This further emphasizes that care has to
be taken: not only MSSA infections but also MRSA
infection can result from intestinal carriage. Since MSSA
and MRSA nasal carriage has been implicated to be a
highly important risk factor for infections, the same will
probably apply to intestinal carriage. Therefore, prospective
controlled studies of intestinal carriage as a predictor of
clinical infection need to be performed to determine the
significance of this site of colonization. Prolonged intestinal
carriage, also among personnel, can be an important factor
Table 7 Intestinal MRSA carriage in young children at risk
Reference Total patients screened Total positive carriers Rectal MRSA Nasal MRSA Rectal without nasal
[74] 128 1 1 0 1
[85] 373 24 7 17 1
[86] 1,792 50 20 35 3
[62] 1,241 29 14 26a 3a
[87] 23 13 9 9 4
Totals 3,557 117 51 87 12
Percentage of total positive carriers 44% 74% 10%
a Throat swab analyzed instead of nasal swab
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in the persistence of MRSA outbreaks in hospitals and can be
a source of environmental contamination. The development of
rapid molecular detection methods for MRSA carriage
facilitates prophylaxis [88]. Nasally applied mupirocin very
effectively eliminates nasal carriage and results in significant
reductions in S. aureus infection rates. Mupirocin seems less
effective for the elimination of intestinal carriage or
other extra-nasal sites. Therefore, application of combined
strategies, involving mupirocin in combination with oral
antibiotics or other selective intestinal decontamination
regiments, such as novel therapies based on polyclonal
antibodies [89], may be more effective in cases of proven
nasal and intestinal carriage. Because of the significant
frequencies of intestinal carriage reported in a wide variety
of patient groups and in healthy people it is recommended,
in addition to nasal screening, to also include intestinal or
perianal screening during surveillance.
Little is known on the age-related kinetics of intestinal
carriage, but S. aureus seems to colonize the intestine of
healthy newborns from very early in life onwards, and can
be involved in the development of neonatal infectious
disease. Later in life, intestinal carriage frequencies seem to
drop. In concordance with nasal carriage, non-, intermittent
and persistent intestinal carriage need to be defined in more
detail. It is, therefore, of importance to determine whether
specific variants of S. aureus are more proficient colonizers
than others and which adhesion and virulence factors play a
role in the transition from intestinal colonization to
infection. Even more importantly, little is known on the
environmental, bacteriological and physiological determi-
nants of intestinal carriage. Preliminary data identify
intestinal carriage as an infection risk factor and results
from cohort studies suggest that there is interrelatedness
among early intestinal colonization of S. aureus, the host’s
immune system, and the development of disease later in
life. Additional research, however, will be needed to fully
appreciate the importance of intestinal S. aureus coloniza-
tion in association with infection.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
References
1. Kluytmans J, van Belkum A, Verbrugh H (1997) Nasal carriage of
Staphylococcus aureus: epidemiology, underlying mechanisms,
and associated risks. Clin Microbiol Rev 10:505–520
2. Weinstein HJ (1959) The relation between the nasal-staphylococcal-
carrier state and the incidence of postoperative complications. N Engl
J Med 260:1303–1308
3. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum
A et al (2005) The role of nasal carriage in Staphylococcus aureus
infections. Lancet Infect Dis 5:751–762
4. Williams RE (1963) Healthy carriage of Staphylococcus aureus:
its prevalence and importance. Bacteriol Rev 27:56–71
5. Larson HE, Price AB, Honour P, Borriello SP (1978) Clostridium
difficile and the aetiology of pseudomembranous colitis. Lancet
311:1063–1066
6. Metan G, Zarakolu P, Unal S (2005) Rapid detection of antibacterial
resistance in emerging Gram-positive cocci. J Hosp Infect 61:93–99
7. Crossley K, Solliday J (1980) Comparison of rectal swabs and
stool cultures for the detection of gastrointestinal carriage of
Staphylococcus aureus. J Clin Microbiol 11:433–434
8. Lee DC, Barlas D, Ryan JG, Ward MF, Sama AE et al (2002)
Methicillin-resistant Staphylococcus aureus and vancomycin-
resistant enterococci: prevalence and predictors of colonization
in patients presenting to the emergency department from nursing
homes. J Am Geriatr Soc 50:1463–1465
9. Meurman O, Routamaa M, Peltonen R (2005) Screening for
methicillin-resistant Staphylococcus aureus: which anatomical
sites to culture. J Hosp Infect 61:351–353
10. Mody L, Kauffman CA, Donabedian S, Zervos M, Bradley SF
(2008) Epidemiology of Staphylococcus aureus colonization in
nursing home residents. Clin Infect Dis 46:1368–1373
11. Drews SJ, Willey BM, Kreiswirth N, Wang M, Ianes T et al (2006)
Verification of the IDI-MRSA assay for detecting methicillin-
resistant Staphylococcus aureus in diverse specimen types in a
core clinical laboratory setting. J Clin Microbiol 44:3794–3796
12. Buehlmann M, Frei R, Fenner L, Dangel M, Fluckiger U et al
(2008) Highly effective regimen for decolonization of methicillin-
resistant Staphylococcus aureus carriers. Infect Control Hosp
Epidemiol 29:510–516
13. Rimland D, Roberson B (1986) Gastrointestinal carriage of
methicillin-resistant Staphylococcus aureus. J Clin Microbiol
24:137–138
14. Matthias JQ, Shooter RA, Williams RE (1957) Staphylococcus
aureus in the faeces of hospital patients. Lancet 272:1172–1173
15. Boe J, Solberg CO, Vogelsang TM, Wormnes A (1964) Perineal
carriers of staphylococci. BMJ 2:280–281
16. Ridley M (1959) Perineal carriage of Staphylococcus aureus. BMJ
1:270–273
17. Dancer SJ, Noble WC (1991) Nasal, axillary, and perineal carriage
of Staphylococcus aureus among women: identification of strains
producing epidermolytic toxin. J Clin Pathol 44:681–684
18. Lee YL, Cesario T, Gupta G, Flionis L, Tran C et al (1997)
Surveillance of colonization and infection with Staphylococcus
aureus susceptible or resistant to methicillin in a community
skilled-nursing facility. Am J Infect Control 25:312–321
19. Roghmann MC, Gorman PH, Wallin MT, Kreisel K, Shurland S et
al (2007) Staphylococcus aureus colonization in community-
dwelling people with spinal cord dysfunction. Arch Phys Med
Rehabil 88:979–983
20. Borer A, Gilad J, Yagupsky P, Peled N, Porat N et al (2002)
Community-acquired methicillin-resistant Staphylococcus aureus
in institutionalized adults with developmental disabilities. Emerg
Infect Dis 8:966–970
21. Van Hal SJ, Stark D, Lockwood B, Marriott D, Harkness J (2007)
Methicillin-resistant Staphylococcus aureus (MRSA) detection:
comparison of two molecular methods (IDI-MRSA PCR assay
and GenoType MRSA Direct PCR assay) with three selective
MRSA agars (MRSA ID, MRSASelect, and CHROMagar
MRSA) for use with infection-control swabs. J Clin Microbiol
45:2486–2490
22. Aeilts GD, Sapico FL, Canawati HN, Malik GM, Montgomerie JZ
(1982) Methicillin-resistant Staphylococcus aureus colonization and
infection in a rehabilitation facility. J Clin Microbiol 16:218–223
124 Eur J Clin Microbiol Infect Dis (2009) 28:115–127
23. Bishop EJ, Grabsch EA, Ballard SA, Mayall B, Xie S et al (2006)
Concurrent analysis of nose and groin swab specimens by the IDI-
MRSA PCR assay is comparable to analysis by individual-
specimen PCR and routine culture assays for detection of
colonization by methicillin-resistant Staphylococcus aureus. J
Clin Microbiol 44:2904–2908
24. Cavalcanti SM, Franca ER, Cabral C, Vilela MA, Montenegro F
et al (2005) Prevalence of Staphylococcus aureus introduced into
intensive care units of a University Hospital. Braz J Infect Dis
9:56–63
25. Coello R, Jimenez J, Garcia M, Arroyo P, Minguez D et al (1994)
Prospective study of infection, colonization and carriage of
methicillin-resistant Staphylococcus aureus in an outbreak affect-
ing 990 patients. Eur J Clin Microbiol Infect Dis 13:74–81
26. Darouiche R, Wright C, Hamill R, Koza M, Lewis D et al (1991)
Eradication of colonization by methicillin-resistant Staphylococcus
aureus by using oral minocycline-rifampin and topical mupirocin.
Antimicrob Agents Chemother 35:1612–1615
27. Eveillard M, de Lassence A, Lancien E, Barnaud G, Ricard JD et
al (2006) Evaluation of a strategy of screening multiple
anatomical sites for methicillin-resistant Staphylococcus aureus
at admission to a teaching hospital. Infect Control Hosp
Epidemiol 27:181–184
28. Gnanalingham KK, Elsaghier A, Kibbler C, Shieff C (2003) The
impact of methicillin-resistant Staphylococcus aureus in a neuro-
surgical unit: a growing problem. J Neurosurg 98:8–13
29. Kampf G, Kramer A (2004) Eradication of methicillin-resistant
Staphylococcus aureus with an antiseptic soap and nasal mupirocin
among colonized patients—an open uncontrolled clinical trial. Ann
Clin Microbiol Antimicrob 3:9
30. KlotzM, Zimmermann S, Opper S, HeegK,Mutters R (2005) Possible
risk for re-colonization with methicillin-resistant Staphylococcus
aureus (MRSA) by faecal transmission. Int J Hyg Environ Health
208:401–405
31. Lim MS, Marshall CL, Spelman D (2006) Carriage of multiple
subtypes of methicillin-resistant Staphylococcus aureus by intensive
care unit patients. Infect Control Hosp Epidemiol 27:1063–1067
32. Maeder K, Ginunas VJ, Montgomerie JZ, Canawati HN (1993)
Methicillin-resistant Staphylococcus aureus (MRSA) colonization
in patients with spinal cord injury. Paraplegia 31:639–644
33. Manian FA, Senkel D, Zack J, Meyer L (2002) Routine screening
for methicillin-resistant Staphylococcus aureus among patients
newly admitted to an acute rehabilitation unit. Infect Control Hosp
Epidemiol 23:516–519
34. Mylotte JM, Kahler L, Graham R, Young L, Goodnough S (2000)
Prospective surveillance for antibiotic-resistant organisms in
patients with spinal cord injury admitted to an acute rehabilitation
unit. Am J Infect Control 28:291–297
35. Papia G, Louie M, Tralla A, Johnson C, Collins V et al (1999)
Screening high-risk patients for methicillin-resistant Staphylococcus
aureus on admission to the hospital: is it cost effective. Infect
Control Hosp Epidemiol 20:473–477
36. Reyes RC, Stoakes L, Milburn S, Lennox G, Daniel J et al (2008)
Evaluation of a new chromogenic medium for the detection of
methicillin-resistant Staphylococcus aureus carriage on nasal and
perianal specimens. Diagn Microbiol Infect Dis 60:225–227
37. Roberts S, Young H, Faulkner S, BilkeyM, Eyres S et al (2002) Value
of broth cultures in detecting methicillin-resistant Staphylococcus
aureus. NZ Med J 115:U191
38. Trick WE, Weinstein RA, DeMarais PL, Kuehnert MJ, Tomaska
W et al (2001) Colonization of skilled-care facility residents with
antimicrobial-resistant pathogens. J Am Geriatr Soc 49:270–276
39. Zhang SX, Drews SJ, Tomassi J, Katz KC (2007) Comparison of
two versions of the IDI-MRSA assay using charcoal swabs for
prospective nasal and nonnasal surveillance samples. J Clin
Microbiol 45:2278–2280
40. Simor AE, Ofner-Agostini M, Paton S, McGeer A, Loeb M et al
(2005) Clinical and epidemiologic features of methicillin-resistant
Staphylococcus aureus in elderly hospitalized patients. Infect
Control Hosp Epidemiol 26:838–841
41. Hare R, Ridley M (1958) Further studies on the transmission of
Staphylococcus aureus. BMJ 1:69–73
42. Solberg CO (2000) Spread of Staphylococcus aureus in hospitals:
causes and prevention. Scand J Infect Dis 32:587–595
43. Masaki H, Asoh N, Watanabe H, Tao M, Watanabe K et al (2003)
Possible relationship between Staphylococcus aureus colonizing
the respiratory tract and rectum and S. aureus isolated in a geriatric
hospital environment. Intern Med 42:281–282
44. Bhalla A, Aron DC, Donskey CJ (2007) Staphylococcus aureus
intestinal colonization is associated with increased frequency of S.
aureus on skin of hospitalized patients. BMC Infect Dis 7:105
45. Boyce JM, Havill NL, Otter JA, Adams NM (2007) Widespread
environmental contamination associated with patients with diarrhea
and methicillin-resistant Staphylococcus aureus colonization of the
gastrointestinal tract. Infect Control Hosp Epidemiol 28:1142–1147
46. Tulloch LG, Alder VG, Gillespie WA (1960) Treatment of chronic
furunculosis. BMJ 2:354–356
47. Solberg CO (1965) A study of carriers of Staphylococcus aureus
with special regard to quantitative bacterial estimations. Acta Med
Scand Suppl 436:1–96
48. Squier C, Rihs JD, Risa KJ, Sagnimeni A, Wagener MM et al
(2002) Staphylococcus aureus rectal carriage and its association
with infections in patients in a surgical intensive care unit and a
liver transplant unit. Infect Control Hosp Epidemiol 23:495–501
49. Ray AJ, Pultz NJ, Bhalla A, Aron DC, Donskey CJ (2003)
Coexistence of vancomycin-resistant enterococci and Staphylococcus
aureus in the intestinal tracts of hospitalized patients. Clin Infect Dis
37:875–881
50. Van Rijen MM, Bonten M, Wenzel RP, Kluytmans JA (2008)
Intranasal mupirocin for reduction of Staphylococcus aureus
infections in surgical patients with nasal carriage: a systematic
review. J Antimicrob Chemother 61:254–261
51. Dupeyron C, Campillo B, Bordes M, Faubert E, Richardet JP et al
(2002) A clinical trial of mupirocin in the eradication of
methicillin-resistant Staphylococcus aureus nasal carriage in a
digestive disease unit. J Hosp Infect 52:281–287
52. Dupeyron C, Campillo B, Richardet JP, Soussy CJ (2006) Long-
term efficacy of mupirocin in the prevention of infections with
meticillin-resistant Staphylococcus aureus in a gastroenterology
unit. J Hosp Infect 63:385–392
53. Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA et al
(2002) Intranasal mupirocin to prevent postoperative Staphylococcus
aureus infections. N Engl J Med 346:1871–1877
54. Harbarth S, Dharan S, Liassine N, Herrault P, Auckenthaler R et al
(1999) Randomized, placebo-controlled, double-blind trial to
evaluate the efficacy of mupirocin for eradicating carriage of
methicillin-resistant Staphylococcus aureus. Antimicrob Agents
Chemother 43:1412–1416
55. Wertheim HF, Verveer J, Boelens HA, van Belkum A, Verbrugh
HA et al (2005) Effect of mupirocin treatment on nasal,
pharyngeal, and perineal carriage of Staphylococcufs aureus in
healthy adults. Antimicrob Agents Chemother 49:1465–1467
56. Falagas ME, Bliziotis IA, Fragoulis KN (2007) Oral rifampin for
eradication of Staphylococcus aureus carriage from healthy and
sick populations: a systematic review of the evidence from
comparative trials. Am J Infect Control 35:106–114
57. Falagas ME, Fragoulis KN, Bliziotis IA (2006) Oral rifampin for
prevention of Staphylococcus aureus carriage-related infections in
patients with renal failure—a meta-analysis of randomized
controlled trials. Nephrol Dial Transplant 21:2536–2542
58. Cerda E, Abella A, de la Cal MA, Lorente JA, Garcia-Hierro P
et al (2007) Enteral vancomycin controls methicillin-resistant
Eur J Clin Microbiol Infect Dis (2009) 28:115–127 125
Staphylococcus aureus endemicity in an intensive care burn unit:
a 9-year prospective study. Ann Surg 245:397–407
59. De la Cal MA, Cerda E, van Saene HK, Garcia-Hierro P, Negro E et
al (2004) Effectiveness and safety of enteral vancomycin to control
endemicity of methicillin-resistant Staphylococcus aureus in a
medical/surgical intensive care unit. J Hosp Infect 56:175–183
60. Silvestri L, van Saene HK, Milanese M, Fontana F, Gregori D et
al (2004) Prevention of MRSA pneumonia by oral vancomycin
decontamination: a randomised trial. Eur Respir J 23:921–926
61. Solis A, Brown D, Hughes J, Van Saene HK, Heaf DP (2003)
Methicillin-resistant Staphylococcus aureus in children with cystic
fibrosis: an eradication protocol. Pediatr Pulmonol 36:189–195
62. Thorburn K, Taylor N, Saladi SM, van Saene HK (2006) Use of
surveillance cultures and enteral vancomycin to control methicillin-
resistant Staphylococcus aureus in a paediatric intensive care unit.
Clin Microbiol Infect 12:35–42
63. Warren DK, Liao RS, Merz LR, Eveland M, Dunne WM Jr (2004)
Detection of methicillin-resistant Staphylococcus aureus directly
from nasal swab specimens by a real-time PCR assay. J Clin
Microbiol 42:5578–5581
64. Furuno JP, Perencevich EN, Johnson JA, Wright MO, McGregor
JC et al (2005) Methicillin-resistant Staphylococcus aureus and
vancomycin-resistant Enterococci co-colonization. Emerg Infect
Dis 11:1539–1544
65. Chen KT, Huard RC, Della-Latta P, Saiman L (2006) Prevalence
of methicillin-sensitive and methicillin-resistant Staphylococcus
aureus in pregnant women. Obstet Gynecol 108:482–487
66. Chen KT, Campbell H, Borrell LN, Huard RC, Saiman L et al
(2007) Predictors and outcomes for pregnant women with vaginal-
rectal carriage of community-associated methicillin-resistant
Staphylococcus aureus. Am J Perinatol 24:235–240
67. FrobergMK, Palavecino E, Dykoski R, GerdingDN, Peterson LR et al
(2004) Staphylococcus aureus and Clostridium difficile cause distinct
pseudomembranous intestinal diseases. Clin Infect Dis 39:747–750
68. Gravet A, Rondeau M, Harf-Monteil C, Grunenberger F, Monteil
H et al (1999) Predominant Staphylococcus aureus isolated from
antibiotic-associated diarrhea is clinically relevant and produces
enterotoxin A and the bicomponent toxin LukE-lukD. J Clin
Microbiol 37:4012–4019
69. Ackermann G, Thomalla S, Ackermann F, Schaumann R, Rodloff
AC et al (2005) Prevalence and characteristics of bacteria and host
factors in an outbreak situation of antibiotic-associated diarrhoea.
J Med Microbiol 54:149–153
70. Boyce JM, Havill NL, Maria B (2005) Frequency and possible
infection control implications of gastrointestinal colonization with
methicillin-resistant Staphylococcus aureus. J Clin Microbiol
43:5992–5995
71. Flemming K, Ackermann G (2007) Prevalence of enterotoxin
producing Staphylococcus aureus in stools of patients with
nosocomial diarrhea. Infection 35:356–358
72. Asha NJ, Tompkins D, Wilcox MH (2006) Comparative analysis of
prevalence, risk factors, and molecular epidemiology of antibiotic-
associated diarrhea due to Clostridium difficile, Clostridium
perfringens, and Staphylococcus aureus. J Clin Microbiol
44:2785–2791
73. Suggs AH, Maranan MC, Boyle-Vavra S, Daum RS (1999)
Methicillin-resistant and borderline methicillin-resistant asymp-
tomatic Staphylococcus aureus colonization in children without
identifiable risk factors. Pediatr Infect Dis J 18:410–414
74. Shahin R, Johnson IL, Jamieson F, McGeer A, Tolkin J et al
(1999) Methicillin-resistant Staphylococcus aureus carriage in a
child care center following a case of disease. Toronto Child Care
Center Study Group. Arch Pediatr Adolesc Med 153:864–868
75. Efuntoye MO, Adetosoye AI (2003) Enterotoxigenicity and drug
sensitivity of staphylococci from children aged five years and
below with sporadic diarrhoea. East Afr Med J 80:656–659
76. Bjorksten B, Naaber P, Sepp E, Mikelsaar M (1999) The intestinal
microflora in allergic Estonian and Swedish 2-year-old children.
Clin Exp Allergy 29:342–346
77. Lindberg E, Adlerberth I, Hesselmar B, Saalman R, Strannegard IL et
al (2004) High rate of transfer of Staphylococcus aureus from
parental skin to infant gut flora. J Clin Microbiol 42:530–534
78. Lindberg E, Nowrouzian F, Adlerberth I, Wold AE (2000) Long-time
persistence of superantigen-producing Staphylococcus aureus strains
in the intestinal microflora of healthy infants. Pediatr Res 48:741–747
79. Lundell AC, Adlerberth I, Lindberg E, Karlsson H, Ekberg S et al
(2007) Increased levels of circulating soluble CD14 but not CD83
in infants are associated with early intestinal colonization with
Staphylococcus aureus. Clin Exp Allergy 37:62–71
80. Adlerberth I, Strachan DP, Matricardi PM, Ahrne S, Orfei L et al
(2007) Gut microbiota and development of atopic eczema in 3
European birth cohorts. J Allergy Clin Immunol 120:343–350
81. Kalliomaki M, Collado MC, Salminen S, Isolauri E (2008) Early
differences in fecal microbiota composition in children may
predict overweight. Am J Clin Nutr 87:534–538
82. Bisgaard H, Hermansen MN, Buchvald F, Loland L, Halkjaer LB
et al (2007) Childhood asthma after bacterial colonization of the
airway in neonates. N Engl J Med 357:1487–1495
83. Michelow IC, Fracchia MS, Kinane TB (2008) Asthma and neonatal
airway colonization. N Engl JMed 358:423–425; author reply 424–425
84. Semic-Jusufagic A, Bachert C, Gevaert P, Holtappels G, Lowe L
et al (2007) Staphylococcus aureus sensitization and allergic
disease in early childhood: population-based birth cohort study. J
Allergy Clin Immunol 119:930–936
85. Singh K, Gavin PJ, Vescio T, Thomson RB Jr, Deddish RB et al
(2003) Microbiologic surveillance using nasal cultures alone is
sufficient for detection of methicillin-resistant Staphylococcus
aureus isolates in neonates. J Clin Microbiol 41:2755–2757
86. Rosenthal A, White D, Churilla S, Brodie S, Katz KC (2006) Optimal
surveillance culture sites for detection of methicillin-resistant
Staphylococcus aureus in newborns. J Clin Microbiol 44:4234–4236
87. Gustafsson EB, Ringberg H, Johansson PJ (2007) MRSA in
children from foreign countries adopted to Swedish families. Acta
Paediatr 96:105–108
88. Carroll KC (2008) Rapid diagnostics for methicillin-resistant
Staphylococcus aureus: current status. Mol Diagn Ther 12:15–24
89. Numan SC, Veldkamp P, Kuijper EJ, van den Berg RJ, van Dissel
JT (2007) Clostridium difficile-associated diarrhoea: bovine anti-
Clostridium difficile whey protein to help aid the prevention of
relapses. Gut 56:888–889
90. Singh N, Squier C, Wannstedt C, Keyes L, Wagener MM et al
(2006) Impact of an aggressive infection control strategy on
endemic Staphylococcus aureus infection in liver transplant
recipients. Infect Control Hosp Epidemiol 27:122–126
91. Grmek-Kosnik I, Ihan A, Dermota U, Rems M, Kosnik M et al
(2005) Evaluation of separate vs pooled swab cultures, different
media, broth enrichment and anatomical sites of screening for the
detection of methicillin-resistant Staphylococcus aureus from
clinical specimens. J Hosp Infect 61:155–161
92. Buttiaux R, Pierret J (1949) Les staphylocoques pathogens dans les
selles des nourissons normaux. Ann Inst Pasteur (Paris) 76:480–482
93. Brodie J, Sommerville T, Wilson SGF (1956) Coagulase positive
staphylococci. A seral survey during the first six months of
nursing training. BMJ 1:667–669
94. Grun L (1958) Studies on intestinal staphylococci. Arch Hyg
Bakteriol 142:3–7
126 Eur J Clin Microbiol Infect Dis (2009) 28:115–127
95. Greendyke RM, Constantine HP, Magruder GB, Dean DC,
Gardner JH et al (1958) Staphylococci on a medical ward, with
special reference to fecal carriers. Am J Clin Pathol 30:318–322
96. Hofstad T, Wormnes A (1961) The effect of broad spectrum
antibiotics on the faecal staphylococcal and monilial flora in man.
Acta Pathol Microbiol Scand 51:275–279
97. Polakoff S, Richards ID, Parker MT, Lidwell OM (1967) Nasal
and skin carriage of Staphylococcus aureus by patients undergo-
ing surgical operation. J Hyg (Lond) 65:559–566
98. Bjorksten B, Sepp E, Julge K, Voor T, Mikelsaar M (2001)
Allergy development and the intestinal microflora during the first
year of life. J Allergy Clin Immunol 108:516–520
Eur J Clin Microbiol Infect Dis (2009) 28:115–127 127
